Skip to main content

Articles

  1. Authors: Ankit Verma, Anna Shteinfer-Kuzmine, Nikita Kamenetsky, Srinivas Pittala, Avijit Paul, Edna Nahon Crystal, Alberto Ouro, Vered Chalifa-Caspi, Swaroop Kumar Pandey, Alon Monsonego, Noga Vardi, Shira Knafo and Varda Shoshan-Barmatz

    The Correction to this article has been published in Translational Neurodegeneration 2023 12:2

Editor-in-Chief

Shengdi Chen, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China 

Aims and Scope

Translational Neurodegeneration is an open access, peer-reviewed journal that covers research, therapeutics and education for all aspects of neurodegenerative diseases. By offering a high-visibility forum for new insights and discussions, Translational Neurodegeneration creates a novel interface between the fields of basic, translational, and clinical research. It includes Parkinson's disease and movement disorders, Alzheimer's disease and other dementias, motor neuron disease and other neurodegenerative diseases.

Read more

Author posts: Behind the Paper

We welcome our authors to share the stories behind their research on Springer Nature Neuroscience Community

Find out more about the research published in Translational Neurodegeneration by reading our authors' Behind the Paper posts. 

sn community

Affiliated with

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 10.8
    5-year Journal Impact Factor: 11.6
    Source Normalized Impact per Paper (SNIP): 2.374
    SCImago Journal Rank (SJR): 3.371

    Speed 2023
    Submission to first editorial decision (median days): 7
    Submission to acceptance (median days): 111

    Usage 2023
    Downloads: 767,289
    Altmetric mentions: 3,389